Bridgeway Capital Management, LLC Ovid Therapeutics Inc. Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 309,540 shares of OVID stock, worth $321,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares

309,540

Previous 352,170 12.1%

Holding current value

$321,921

Previous $271,000 34.69%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.75 - $1.3 $31,972 - $55,419	-42,630 Reduced 12.1%	309,540 $365,000
Q2 2024 Aug 14, 2024	SELL	$0.7 - $3.34 $3,989 - $19,038	-5,700 Reduced 1.59%	352,170 $271,000
Q1 2024 May 15, 2024	SELL	$2.72 - $4.04 $221,612 - $329,159	-81,475 Reduced 18.54%	357,870 $1.09 Million
Q4 2023 Feb 14, 2024	SELL	$2.98 - $3.78 $57,677 - $73,161	-19,355 Reduced 4.22%	439,345 $1.41 Million
Q3 2023 Nov 14, 2023	SELL	$3.23 - $3.97 $1.11 Million - $1.36 Million	-342,452 Reduced 42.74%	458,700 $1.76 Million
Q2 2023 Aug 14, 2023	SELL	$2.53 - $3.89 $66,862 - $102,804	-26,428 Reduced 3.19%	801,152 $2.63 Million
Q1 2023 May 15, 2023	SELL	$1.88 - $2.85 $157,205 - $238,317	-83,620 Reduced 9.18%	827,580 $2.14 Million
Q4 2022 Feb 14, 2023	BUY	$1.43 - $1.89 $3,861 - $5,103	2,700 Added 0.3%	911,200 $1.69 Million
Q3 2022 Nov 14, 2022	SELL	$1.84 - $2.26 $138,368 - $169,951	-75,200 Reduced 7.64%	908,500 $1.67 Million
Q2 2022 Aug 15, 2022	BUY	$1.69 - $3.31 $1.04 Million - $2.04 Million	615,600 Added 167.24%	983,700 $2.12 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $415,255 - $546,883	156,700 Added 74.12%	368,100 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $59,400 - $80,820	-18,000 Reduced 7.85%	211,400 $827,000
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $555,148 - $1.03 Million	229,400 New	229,400 $922,000
Q2 2020 Aug 14, 2020	SELL	$2.67 - $7.91 $647,742 - $1.92 Million	-242,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $67,392 - $163,944	32,400 Added 15.41%	242,600 $1.01 Million
Q3 2019 Nov 14, 2019	BUY	$1.76 - $3.51 $264,000 - $526,500	150,000 Added 249.17%	210,200 $681,000
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $38,541 - $51,873	-24,240 Reduced 28.71%	60,200 $111,000
Q1 2019 May 15, 2019	SELL	$1.77 - $3.56 $24,780 - $49,840	-14,000 Reduced 14.22%	84,440 $149,000
Q4 2018 Feb 14, 2019	SELL	$2.42 - $6.6 $24,200 - $66,000	-10,000 Reduced 9.22%	98,440 $238,000
Q1 2018 May 15, 2018	BUY	$6.53 - $9.82 $388,143 - $583,700	59,440 Added 121.31%	108,440 $767,000
Q4 2017 Feb 14, 2018	BUY	$6.12 - $12.31 $299,880 - $603,190	49,000	49,000 $484,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39M

Call Options Held

37.4K

Put Options Held

500

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Ovid Therapeutics Inc. Transaction History